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Cigarette smoking is a major modifiable risk factor for
cardiovascular disease (CVD) [1]. Cigarette smoking
accounts for approximately 400 million deaths each year
worldwide. Reportedly, about 70% of smoking deaths
have taken place in Asian countries [2]. Cigarette
smoking is considered to be the first leading preventable
cause of death in Korean men. According to the fourth
Korean National Health and Nutrition Examination
Survey in 2007, of persons 20 years or older, the
smoking rate in South Korea was 50.8% for men and
3.2% for women [3]. 
Serum bilirubin, which is a bile pigment, is known as
a major breakdown product of heme catabolism and thus
is highly related to hemoglobin [4]. Bilirubin circulates
in the bloodstream in two forms: direct and indirect. It
has been found to have potent endogenous antioxidant
properties in in vitro studies, whether in direct or indirect
form. It protects lipid membranes, protein albumin, and
other proteins, especially in areas consisting of poor
antioxidant defense systems such as the myocardium
and nervous system [5,6]. Bilirubin concentrations were
found to have inverse associations with the risk of CVD,
stroke, and metabolic syndrome [7-9]. The serum
bilirubin subtypes, especially direct bilirubin, have also
been found to have significant associations with
metabolic syndrome components including central
obesity, hypertriglyceridemia, hyperglycemia, and low
levels of high-density lipoprotein cholesterol (HDL-C)
for both genders [10]. Still, studies identifying the
impact of serum bilirubin subtypes on the risk of CVD,
stroke, and metabolic syndrome are scarce. 
An association between cigarette smoking and serum
bilirubin has been suggested by some studies. In these
studies, smoking was associated with decreased serum
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Objectives: Cigarette smoking is a modifiable risk factor for cardiovascular disease. Bilirubin is a potent antioxidant and
its concentration decreases in smokers. However, studies about the association between cigarette smoking and bilirubin
are scarce and most are limited to total bilirubin. Additionally, bilirubin is highly related to hemoglobin. Therefore, this
study evaluates the association between bilirubin subtypes and cigarette smoking in healthy Korean men independently of
hemoglobin.
Methods: This study included 48 040  Korean men aged 30 to 87 years who visited the Korea Medical Institute for routine
health examinations from January to December, 2007. The association of smoking with total, direct, and indirect bilirubin
was assessed by logistic regression analysis taking into consideration differences in subjects and smoking characteristics.
Results: Current smokers had lower bilirubin concentrations than never-smokers and ex-smokers. Smoking amount and
duration were inversely significantly associated with total, direct, and indirect bilirubin. In a multivariable adjusted model,
compared to never-smokers, the odds ratios (ORs) and 95% confidence intervals (CIs) of current smokers with the highest
number of pack-years were 1.7 (1.6 to 1.9) for total, 1.5 (1.4 to 1.6) for direct, and 1.7 (1.6 to 1.9) for indirect bilirubin.
After further adjustment for hemoglobin, this association became stronger (OR [95% CI], 2.1 [1.9 to 2.2] for total; 1.9 [1.8
to 2.0] for direct; 2.0 [1.9 to 2.2] for indirect bilirubin).
Conclusions: In this study, bilirubin subtypes are inversely associated with smoking status, smoking amount, and
smoking duration in healthy Korean men independently of hemoglobin. Further studies are needed to investigate this
association in healthy Korean women. 
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bilirubin concentrations [11-14]. However, smoking was
also found to have a significant association with
hemoglobin, which regulates bilirubin concentrations
[15,16]. Whether smoking can be affected by
hemoglobin in relation to bilirubin is still questionable.
Moreover, most of the previous data on cigarette
smoking in relation to serum bilirubin has been limited
to total bilirubin. Therefore, we evaluated the association
between bilirubin subtypes and cigarette smoking status,
smoking intensity, and duration of current smoking in
healthy Korean men independently of hemoglobin
levels.
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I. Study Subjects
This study included 55183 Korean men aged 30 to 89
years who visited the Korea Medical Institute (KMI)
from January, 2007 to December, 2007. Of the 55 183
participants, 551 aged <30 years were excluded for
having missing data for bilirubin subtypes: total, direct,
and indirect bilirubin. Another 734 were excluded for
having missing data for systolic blood pressure, diastolic
blood pressure, waist circumference, triglycerides,
fasting serum glucose, and alcohol consumption.
Participants with total bilirubin >34.2 mol/L (2 mg/dL)
were excluded due to a high possibility of Gilbert’s
syndrome [9]. Furthermore, 119 participants with a past
history of CVD and liver diseases identified in the self-
questionnaire and 337 who had a history of cancer,
CVD, stroke, diabetes, or hypertension were also
excluded. Therefore, the study population was finalized
as 48 040 Korean men. Recruitment of volunteers only
took place after obtaining written informed consent. The
Institutional Review Board of Human Research of
Yonsei University approved the study. 
II. Data Collection
During a standardized examination at KMI,
participants were asked whether they had ever smoked
or whether they exercised regularly via a standardized
health questionnaire. Demographic characteristics
including age, gender, family history, and past history of
clinical diseases, as well as cigarette smoking status
(never-smoker, ex-smoker, or current-smoker) and
alcohol consumption status (never-drinker and ever-
drinker) were also collected. Both current- and ex-
smokers were asked to report the average number of
cigarettes per day they smoked at the time or had
smoked earlier. Waist circumference was measured
midway between the lower rib and iliac crest. Pack-years
(PYR) were calculated as follows: PYR=smoking
amount (cigarettes/d) period of smoking (y)/20.
For clinical chemistry assays, serum was separated
from peripheral venous blood samples obtained from
Table 1. General characteristics of Korean men according to smoking status
Age (y)
Body mass index (kg/m2)
Waist circumference (cm)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Total cholesterol (mg/dL)
Triglyceride (mg/dL)
HDL cholesterol (mg/dL)
Fasting serum glucose (mg/dL)
Total bilirubin ( mol/L)
Direct bilirubin ( mol/L)
Indirect bilirubin ( mol/L)
Hemoglobin (g/L)
Alanine aminotransferase (U/L)
Aspartate aminotransferase (U/L)
Gamma-glutamyltransferase (U/L)
Uric acid (mg/dL)
Alcohol intake
No
Yes
Never smoker (n=14 992) Ex-smoker (n=11 041) Current smoker (n=22 007)
041.5?8.4
024.2?2.8
084.1?9.8
120.8?12.7
076.0?9.1
192.9?32.7
146.7?90.0
048.7?8.3
091.8?18.7
016.1?5.6
006.0?2.0
010.1?3.9
015.0?0.9
025.1?14.2
030.1?25.2
039.9?40.7
006.1?1.2
20.9
79.1
043.0?8.0
024.5?2.7
085.2?10.6
121.1?12.4
076.6?8.8
195.6?32.7
159.3?98.8
048.6?8.3
093.0?20.1
015.9?5.4
005.8?2.0
009.8?3.7
015.2?0.9
025.9?13.9
030.8?23.9
046.8?46.8
006.2?1.2
10.5
89.5
040.2?7.2
024.5?3.0
085.2?13.4
119.8?12.5
075.6?9.1
195.2?33.6
178.0?109.0
047.9?8.1
091.5?20.8
014.8?5.3
005.3?1.9
009.2?3.6
015.5?1.0
025.6?17.9
031.9?25.7
054.1?63.1
006.3?1.2
07.8
92.2
Values are presented as mean?SD or percent.
All of the above differences were statistically significant (p<0.05) by ANOVA or the chi-square test.
HDL, high-density lipoprotein. 
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each participant after 12 hours of fasting. Serum
bilirubin, fasting blood glucose, total cholesterol,
triglycerides, and HDL-C were measured using a
Hitachi-7600 analyzer (Hitachi Ltd., Tokyo, Japan). The
body mass index (BMI) was calculated as weight (kg)
divided by the square of height (m2). 
III. Statistical Analysis
Data were expressed as mean?standard deviation.
ANOVA was used to analyze statistical differences
among the characteristics of the study participants.
Current-smokers were classified into groups smoking 1
to 9, 10 to 19, and 20 or more cigarettes per day.
Smokers were further classified into groups by duration
of smoking of 1 to 12, 13 to 21, and 22 or more years.
Multiple logistic regression analysis was employed to
identify the association between cigarette smoking and
serum bilirubin subtypes in current smokers. To examine
the association between smoking status and total serum
bilirubin, stratified by age, BMI, hypertension, diabetes,
triglyceride (TG)/HDL-C, and alcohol intake, samples
were divided into groups by median value of age (<40
and ?40), BMI (<23 and ?23), hypertension (yes and
no), diabetes (yes and no), TG/HDL-C (<3 and ?3) and
alcohol intake (yes and no). Hypobilirubinemia was
defined as the lowest quartile of bilirubin subtypes [17].
All analysis was conducted using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA). All statistical tests
were two-sided and statistical significance was
determined as p<0.05.
???????
Table 1 shows the general characteristics of Korean
men (n=48 040) in relation to smoking status. The
percentages of participants aged 30 to 89 years classified
as never-smokers, ex-smokers, and current-smokers
were 31.2%, 23.0%, and 45.8%, respectively. Never-
smokers were younger, on average, than ex-smokers and
older than current-smokers. Compared to never-
smokers, ex-smokers and current-smokers had a larger
average waist circumference, and higher levels of total
Figure 1. Means of total, direct and indirect serum bilirubin versus cigarette smoking among Korean men (p for
trend < 0.01). (A) Smoking status. (B) smoking amount (cigarettes/d) in current smokers. (C) Smoking duration (y)
in current smokers. (D) Pack-years in current smokers.
TB, total bilirubin; DB, direct bilirubin; IDB, indirect bilirubin.
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cholesterol, triglycerides, alanine aminotransferase
(ALT), and gamma-glutamyl transferase (GGT).
However, HDL-C and serum bilirubin subtype levels
were lower in ex-smokers and current-smokers than
never-smokers. All of these differences were statistically
significant (p < 0.05). Mean total serum bilirubin
concentrations were 14.8 mol/L and 16.1 mol/L in
current-smokers and never-smokers, respectively.
Additionally, mean concentrations of total, direct, and
indirect serum bilirubin decreased with increasing
numbers of cigarettes smoked per day, period of
smoking, and PYR in current-smokers (Figure 1).
Table 2 details the multiple logistic regression model
of the lowest quartile of serum bilirubin subtypes
compared to the highest quartile in current-smokers
among men. After adjusting for age, BMI, ALT, GGT,
uric acid, and alcohol consumption in model I, serum
bilirubin subtypes, including total, direct, and indirect
bilirubin, were inversely significantly associated with
smoking amount, smoking duration, and PYR. When
hemoglobin was further adjusted in model II, these
associations of serum bilirubin subtypes with smoking
amount and PYR remained statistically significant and
were even stronger. However, the association between
serum bilirubin subtypes and smoking duration
remained the same after further adjusting for
hemoglobin. In model I, compared to never smokers, the
odds ratios (ORs) and 95% confidence intervals (CI) of
current smokers with PYR ?20 years for the lowest
quartile of serum bilirubin subtypes were 1.7 (1.6-1.9)
for total, 1.5 (1.4-1.6) for direct, and 1.7 (1.6-1.9) for
indirect bilirubin whereas the ORs (95% CI) of current
smokers with pack-years ?20 years, compared to never
smokers, for the lowest quartile of serum bilirubin
subtypes increased to 2.1 (1.9-2.2) for total, 1.9 (1.8-
2.0) for direct, and 2.0 (1.9-2.2) for indirect bilirubin in
model II.
Current smokers were grouped according to the
quantity of cigarettes smoked per day (0, 1-9, 10-19, and
20 or more) in order to examine the association between
smoking intensity and total serum bilirubin
concentration. The data were further stratified by age,
BMI, hypertension, diabetes, TG/HDL-C ratio, and
alcohol intake (Table 3). Compared to never-smokers,
ORs (95% CI) for the lowest quartile of total bilirubin
increased in men who smoked more than 20 cigarettes
per day to 1.6 (1.4-1.7) and 1.6 (1.5-1.7), with age <40
and age ?40 years, respectively. In addition, men who
drank and smoked more than 20 cigarettes per day had
an OR (95% CI) of 1.6 (1.5-1.7) whereas men who did
not drink and smoke more than 20 cigarettes per day had
an OR (95% CI) of 1.9 (1.7-2.2). Similar relationships
between total serum bilirubin and smoking intensity
were seen in BMI, hypertension, diabetes, and TG/HDL-
C ratios. 
Table 2. Multivariable adjusted odds ratios and 95% confidence intervals for the lowest quartile of bilirubin
subtypes compared to the highest quartile of bilirubin subtypes according to cigarette smoking in current male
smokers
Cigarette smoking
Serum bilirubin subtypes
n
Total bilirubin
n1 Model I2 Model II3
Direct bilirubin
n1 Model I2 Model II3
Indirect bilirubin
n1 Model I2 Model II3
Smoking amount (cigarette/d)
Never smoker
1 - 9
10 - 19
?20
Smoking duration (y)
Never smoker
1 - 12
13 - 21
?22
Pack-years4
Never smoker
1 - 6
7 - 19
?20
14992
4535
15481
10151
14992
8047
16501
8254
14992
7360
14548
7576
2896
916
3799
2765
2896
1631
4022
2279
2896
1511
3585
2200
1.0 
1.1 (1.0, 1.2)
1.5 (1.4, 1.6)
1.8 (1.6, 1.9)
1.0 
1.1 (1.1, 1.2)
1.5 (1.4, 1.6)
1.9 (1.8, 2.0)
1.0 
1.1 (1.1, 1.2)
1.4 (1.4, 1.5)
1.7 (1.6, 1.9)
1.0 
1.2 (1.1, 1.3)
1.6 (1.5, 1.7)
1.9 (1.8, 2.0)
1.0 
1.1 (1.1, 1.2)
1.5 (1.4, 1.6)
1.9 (1.8, 2.0)
1.0 
1.2 (1.1, 1.3)
1.6 (1.5, 1.6)
2.1 (1.9, 2.2)
3397
1056
4080
2966
3397
1814
4301
2458
3397
1695
3827
2376
1.0 
1.2 (1.1, 1.3)
1.4 (1.3, 1.5)
1.7 (1.6, 1.8)
1.0 
1.1 (1.1, 1.2)
1.4 (1.3, 1.5)
1.8 (1.7, 1.9)
1.0 
1.1 (1.0, 1.2)
1.4 (1.3, 1.4)
1.5 (1.4, 1.6)
1.0 
1.2 (1.1, 1.3)
1.5 (1.4, 1.5)
1.8 (1.7, 1.9)
1.0 
1.1 (1.1, 1.2)
1.4 (1.3, 1.5)
1.8 (1.7, 1.9)
1.0 
1.2 (1.1, 1.3)
1.5 (1.4, 1.5)
1.9 (1.8, 2.0)
1927
612
2679
1950
1927
1106
2835
1608
1927
1011
2552
1548
1.0 
1.1 (1.0, 1.2)
1.5 (1.4, 1.6)
1.7 (1.6, 1.8)
1.0 
1.1 (1.0, 1.2)
1.5 (1.4, 1.6)
1.8 (1.7, 2.0)
1.0 
1.1 (1.0, 1.2)
1.4 (1.3, 1.5)
1.7 (1.6, 1.9)
1.0 
1.1 (1.0, 1.2)
1.6 (1.5, 1.7)
1.9 (1.7, 2.0)
1.0 
1.1 (1.0, 1.2)
1.5 (1.4, 1.6)
1.8 (1.7, 2.0)
1.0 
1.1 (1.0, 1.2)
1.6 (1.5, 1.7)
2.0 (1.9, 2.2)
1 The number of the lowest quartile of bilirubin subtypes (total bilirubin, direct bilirubin, indirect bilirubin).
2 Adjusted for age, alanine aminotransferase, gamma-glutamyltransferase, uric acid, body mass index, and alcohol consumption.
3 Adjusted for age, alanine aminotransferase, gamma-glutamyltransferase, uric acid, body mass index, alcohol consumption and hemoglobin.
4 Pack-years were calculated as amount (cigarettes/d) x period of smoking (y)/20.
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Our study demonstrated that cigarette smoking is
associated with lower concentrations of serum bilirubin
among healthy Korean men. Lower concentrations of
serum bilirubin subtypes, including total, direct, and
indirect, were found in ex- and current smokers than
never smokers. Additionally, concentrations of serum
bilirubin subtypes decreased with increasing numbers of
cigarettes smoked per day, period of smoking, and PYR
among current-smokers. In this study, these significant
associations were independent of hemoglobin levels. 
Cigarette smoking is known to be a modifiable risk
factor for CVD and the leading cause of death in Korea.
The association between cigarette smoking and serum
bilirubin concentration has been described previously
[11-14]. In a study among the Belgian population, total
serum bilirubin concentration was lower in male
smokers and intermediate in former-smokers compared
with never-smokers. Although lower concentrations of
total serum bilirubin were found in female smokers, the
difference was not significant [14]. In a study among US
residents, a significant inverse association between
smoking and total serum bilirubin was found. In
particular, this inverse association occurred in subjects
without coronary artery disease (CAD) and subjects with
minimal CAD and severe CAD [13]. Although inverse
associations between total serum bilirubin and smoking
status were reported in these studies, the importance of
bilirubin as an antioxidant affected by smoking needs
further investigation. However, cigarette smoking is also
found to be positively associated with hemoglobin,
which regulates bilirubin concentrations [15,16].
Therefore, differences in bilirubin levels may be due to
hemoglobin concentrations. Still, these studies showing
the significant associations between total serum bilirubin
and smoking were independent of hemoglobin. 
Regarding the relationship between smoking and
bilirubin subtypes, total, direct, and indirect bilirubin
have been consistently shown to be lower in current-
smokers than never-smokers. In a study examining the
relationship of serum bilirubin subtypes with ischemic
stroke, those with higher levels of direct bilirubin had
more acute severe stroke than those with lower levels of
direct serum bilirubin. Direct serum bilirubin was
significantly associated with initial stroke severity,
whereas total bilirubin was not. It is still unclear why
serum bilirubin, especially direct bilirubin, was
significantly associated with initial stroke [18]. In
addition, in the relationship of direct bilirubin to
metabolic syndrome analyzed in a recent study, the
highest quartile of serum direct bilirubin was associated
with a 40% to 70% reduced risk of metabolic syndrome
relative to the lowest quartile in both men and women.
Table 3. ORs and 95% CIs for the lowest quartile of total bilirubin concentration compared to the highest quartile
of total bilirubin concentrations according to age, BMI, hypertension, diabetes, TG/HDL-C, and alcohol intake in
current male smokers
Variables
Smoking amount (cigarette/d)
NS1
1-9
n OR (95% CI)
Age (y)
<40
?40
BMI (kg/m2)
<23
?23
Hypertension
No
Yes
Diabetes
No
Yes
TG/HDL-C (mg/dL)
<3
?3
Alcohol intake
No
Yes
7305
7687
10221
22827
12869
2123
14445
547
8990
6002
3106
11731
2597
1938
1592
2943
3985
550
4403
132
2551
1984
379
4110
1.1 (0.9, 1.2)
1.1 (1.0, 1.3)
1.1 (0.9, 1.2)
1.1 (1.0, 1.2)
1.2 (0.9, 1.5)
1.1 (1.0, 1.2)
1.3 (0.8, 1.9)
1.1 (1.0, 1.2)
1.2 (1.1, 1.3)
1.0 (0.9, 1.1)
1.0 (0.8, 1.3)
1.1 (1.0, 1.2)
10-19
n OR (95% CI)
8134
7347
4975
10506
13464
2017
14911
570
7721
7760
1279
14045
1.4 (1.3, 1.5)
1.4 (1.3, 1.5)
1.5 (1.4, 1.7)
1.3 (1.2, 1.4)
1.2 (1.1, 1.4)
1.4 (1.3, 1.5)
1.2 (1.0, 1.6)
1.4 (1.3, 1.5)
1.4 (1.3, 1.5)
1.3 (1.2, 1.4)
1.9 (1.6, 2.1)
1.4 (1.3, 1.5)
?20
n OR (95% CI)
3548
6603
2782
7369
8484
1667
9506
645
4474
5677
1055
8942
1.6 (1.4, 1.7)
1.6 (1.5, 1.7)
1.8 (1.7, 2.1)
1.5 (1.4, 1.6)
1.4 (1.2, 1.6)
1.6 (1.5, 1.7)
1.5 (1.2, 1.9)
1.6 (1.5, 1.7)
1.6 (1.5, 1.7)
1.5 (1.4, 1.6)
1.9 (1.7, 2.2)
1.6 (1.5, 1.7)
OR, odds ratio; CI, confidence interval; NS, never smoker; BMI, body mass index; TG, triglycerides; HDL-C, high density lipoprotein cholesterol. 
p for interaction = 0.158.
1 The baseline risk.
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Furthermore, women of the top quartile of serum total
bilirubin and serum indirect bilirubin had a 35% and
20% lower rate of the metabolic syndrome, respectively
[19]. Some studies indicated that direct bilirubin might
act on the target organ and molecule because direct
bilirubin is weakly bound to albumin, thus easily
separated from albumin and converted into active form
than the other bilirubin subtypes [20]. Still, a variety of
epidemiological studies among individuals with general
medical conditions including hepatic disease have
suggested that the direct bilirubin concentration may
have a better prognostic value than total bilirubin
concentration [18-23]. However, in our study, direct
bilirubin together with total and indirect serum bilirubin
was significantly associated with smoking among
Korean men. Furthermore, total, direct, and indirect
serum bilirubin subtypes decreased with increasing
smoking amount and duration. From a recent study, the
duration of smoking was found to be a more important
determinant of serum bilirubin concentration than the
number of cigarettes smoked per day [14]. However, in
that study, smoking duration was an important
determinant of serum bilirubin concentration together
with smoking amount. 
In this study, an increased risk of having total bilirubin
in the lowest quartile was obtained with increasing
numbers of cigarettes smoked per day among current
smokers in the strata of age, BMI, hypertension,
diabetes, TG/HDL-C, and alcohol intake. In particular,
these associations were statistically stronger in men who
smoked more than 20 cigarettes per day and had a BMI
<23 kg/m2, hypertension, diabetes, or TG/HDL-C <3, or
who did not drink alcohol. 
Bilirubin, which is a bile pigment, is generally
regarded as a waste product of heme catabolism.
However, it has been suggested that bilirubin might play
an important role as an antioxidant, and its role as an
antioxidant in vitro has recently been identified [24-28].
A number of recent in vitro studies have shown that
bilirubin is more efficient than ?-tocopherol at inhibiting
low-density lipoprotein (LDL) oxidation and is a more
efficient protector of human ventricular myocytes than
either vitamin C or vitamin E [29-32]. Cigarette smoke
contains a large quantity of free radicals, resulting in
endothelial injury [33]. LDL oxidation appears as an
early event of atherosclerosis and increases with cigarette
smoking [34-36]. In this study, low serum bilirubin
levels could have been caused by overconsumption of
free-radicals produced mostly by cigarette smoking. 
This study has several limitations. Due to its cross-
sectional design, the present study precluded the
determination of causality. Bilirubin concentrations were
measured only once. Another limitation may be that this
study was performed only among men due to the small
number of female Korean smokers. However, the main
strength of this study is that to our knowledge it is a large
sample size used to evaluate the inverse association
between bilirubin concentration and cigarette smoking
among Korean men. Most published studies have been
limited to Caucasians rather than Asians. Second,
Gilbert’s syndrome is a genetic disorder of bilirubin
metabolism that can result in production of elevated
levels of indirect bilirubin in the bloodstream without
any serious consequences [37]. In Korea, participants
with Gilbert’s syndrome have been shown to have a low
prevalence and incidence of coronary heart diseases and
higher levels of high density lipoprotein and antioxidant
levels [38]. In this study, to clarify the results, only
apparently healthy Korean men without a high
possibility of having Gilbert’s syndrome (total bilirubin
concentrations >34.2 mol/L) [9] or any other diseases,
which might affect the association between serum
bilirubin and smoking, were included in the study. Still,
total bilirubin concentrations >34.2 mol/L is not the
definition or exclusion of Gilbert’s syndrome. We also
could not find any differences in the risk of having
hypobilirubinemia when we included the participants
with Gilbert’s syndrome. The association between serum
bilirubin and smoking remained significant after the
exclusions. Finally, participants in the KMI study were
mostly workers; therefore, they were mostly younger
than those in the Korean National Health and Nutrition
Examination Survey data. 
In conclusion, cigarette smoking decreases all three
types of serum bilirubin in apparently health Korean men
independently of hemoglobin. Bilirubin is inexpensive
and easily measured in most clinical laboratories. Further
studies are needed to determine if measuring bilirubin is
effective in detecting free-radicals produced by smoking,
which contribute to serious diseases including CVD.
Additionally, further investigations should be carried out
to determine whether such associations also exist among
apparently healthy Korean women. 
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